Focus: Ophtec is a Netherlands-based biotechnology company specializing in intraocular lenses and ophthalmology products for conditions like aphakia, presbyopia, and cataracts. The company operates as a focused medical device innovator in the ophthalmology segment.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Ophtec to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Implantable lens for post-cataract aphakic correction with established clinical trial support.
Help build intelligence for Ophtec
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ophtec's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Addresses presbyopia correction, a major unmet need in aging populations globally.
Premium presbyopic intraocular lens for cataract surgery patients seeking vision correction.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo